Analysis

Biotechnology firm United Therapeutics enters a pivotal period as market participants await a major medical conference presentation. The company's stock...

DuPont de Nemours finds itself navigating turbulent financial waters as it pursues an ambitious corporate overhaul. The specialty chemicals giant...

Friday proved to be a turbulent day for pharmaceutical giant Eli Lilly, with three significant developments creating a complex picture...

Shares of real estate franchising giant RE/MAX experienced a notable surge this week, climbing nearly 6% and breaking a prolonged...

Meritage Homes finds itself operating within a highly dynamic residential construction sector, balancing strategic corporate initiatives against a backdrop of...

A recent federal appeals court decision has created fresh challenges for Alphabet Inc., mandating significant operational changes to Google's Play...

The investment community appears deeply divided on the prospects for coatings giant Sherwin-Williams. Following a disappointing quarterly earnings report and...

Rocky Brands finds itself at a fascinating juncture, presenting investors with a complex puzzle of bullish fundamentals, strong institutional backing,...

The entertainment technology provider Xperi finds itself confronting significant challenges on multiple fronts. New European data regulations have emerged during...

Cardano's ADA token is currently trading within a narrow band between $0.88 and $0.90, approaching a decisive moment for its...